{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:58:54Z","timestamp":1777503534222,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Kidney Health Dis"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Metabolic acidosis is a common complication of kidney failure that is treated with bicarbonate supplementation. The addition of bicarbonate to the dialysis solution and oral bicarbonate supplementation are used to treat metabolic acidosis in patients receiving dialysis, but the treatment approach that is best for patient health remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The purpose of this study was to determine whether the concentration of dialysate bicarbonate or the use of oral bicarbonate supplementation alters the risk of mortality, hospitalizations, cardiovascular and nutritional outcomes, and laboratory measurements in patients treated with maintenance dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Any country of origin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Adult patients (\u226518 years) receiving maintenance dialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements:<\/jats:title>\n                    <jats:p>Extracted data included demographic characteristics and outcomes such as mortality, hospitalizations, cardiovascular events, surrogate markers of nutrition, and pre-dialysis and post-dialysis levels of serum bicarbonate, pH, calcium, potassium, and parathyroid hormone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We searched MEDLINE, Embase, CENTRAL, and Google Scholar through October 7, 2024 for studies examining dialysate bicarbonate concentration and\/or oral bicarbonate supplementation in adults undergoing maintenance dialysis. Meta-analysis was performed for pre-dialysis serum bicarbonate and for pre-dialysis and post-dialysis calcium and potassium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified 37 studies (n = 24,782 patients) with patients treated with hemodialysis (13 randomized trials, 10 non-randomized interventional studies, 14 observational studies) and 4 studies (n = 347 patients) with patients receiving peritoneal dialysis (3 randomized trials, 1 non-randomized interventional study). No randomized trials reported mortality or hospitalizations in hemodialysis patients. Studies reporting cardiovascular outcomes (n = 20) were small with inconsistent results. Most studies reporting nutritional outcomes (n = 21) reported no significant differences with dialysate bicarbonate concentration or oral bicarbonate supplementation but were small in sample size (largest study n = 200). Meta-analysis of parallel-group randomized trials comparing dialysate bicarbonate &gt;35 mmol\/L with \u226435 mmol\/L found a mean difference of 3.5 mmol\/L (95% confidence interval [CI] \u22120.6 to 7.7) in pre-dialysis serum bicarbonate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>Non-English and gray literature were excluded. Most studies were small or observational in nature, and heterogeneity further limited the ability to perform meta-analysis of outcomes such as mortality, hospitalizations, and cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The evidence for the effect of higher vs lower dialysate bicarbonate concentration and oral bicarbonate supplementation on clinical outcomes in dialysis patients is very uncertain. There is a need for large, high-quality randomized controlled trials in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20543581251356182","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:01:38Z","timestamp":1754024498000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Dialysate Bicarbonate Concentration or Oral Bicarbonate Supplementation on Outcomes in Patients on Maintenance Dialysis: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"12","author":[{"given":"Ashlee M.","family":"Azizudin","sequence":"first","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-6131","authenticated-orcid":false,"given":"Samuel A.","family":"Silver","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3398-3114","authenticated-orcid":false,"given":"Amit X.","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Western University, London, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe K.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-969X","authenticated-orcid":false,"given":"Andrea C.","family":"Cowan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, Western University, London, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-5958","authenticated-orcid":false,"given":"Catherine M.","family":"Clase","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"},{"name":"Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-0202","authenticated-orcid":false,"given":"Amber O.","family":"Molnar","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"},{"name":"Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.05.006"},{"key":"e_1_3_2_3_2","article-title":"Clinical practice guidelines for nutrition in chronic renal failure","volume":"35","author":"K\/DOQI National Kidney Foundation","year":"2000","unstructured":"K\/DOQI National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35:S17-S104.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.03.035"},{"key":"e_1_3_2_5_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"e_1_3_2_6_2","unstructured":"Rohatgi A. Webplotdigitizer: version 4.4. 2020. https:\/\/automeris.io\/. Accessed June 25 2025."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0145445516673998"},{"key":"e_1_3_2_8_2","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"e_1_3_2_9_2","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"e_1_3_2_10_2","unstructured":"Wells G Shea B O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2013. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\/. Accessed June 25 2025."},{"key":"e_1_3_2_11_2","first-page":"252","volume-title":"JBI Manual for Evidence Synthesis","author":"Moola S","year":"2020","unstructured":"Moola S, Munn Z, Tufanaru C, et al. Systematic reviews of etiology and risk. In: Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, eds. JBI Manual for Evidence Synthesis. Adelaide, SA, Australia: JBI; 2020:252-311."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39490.551019.BE"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.01.006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V3111804"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2094805"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02549-x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12842"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12502"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v31.pm9428449"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1989.309"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.15171\/jrip.2016.32"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.5301\/jn.5000036"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn541"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087193"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg383"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.12.2633"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-014-0844-5"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.11.2006"},{"issue":"3","key":"e_1_3_2_29_2","first-page":"1003","article-title":"Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration","volume":"14","author":"Montagud-Marrahi E","year":"2020","unstructured":"Montagud-Marrahi E, Broseta J, Rodriguez-Espinosa D, et al. Optimization of dialysate bicarbonate in patients treated with online haemodiafiltration. Clin Kidney J. 2020;14(3):1003-1013.","journal-title":"Clin Kidney J"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.12510"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000368459"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2007.5.2.95"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-2276(03)00092-X"},{"issue":"4","key":"e_1_3_2_34_2","first-page":"449","article-title":"The role of oral sodium bicarbonate supplementation in maintaining acid\u2014base balance and its influence on the cardiovascular system in chronic hemodialysis patients\u2014results of a prospective study","volume":"9","author":"Voicule\u021b C","year":"2016","unstructured":"Voicule\u021b C, Zar\u0103 O, Bogeanu C, V\u0103c\u0103roiu I, Aron G. The role of oral sodium bicarbonate supplementation in maintaining acid\u2014base balance and its influence on the cardiovascular system in chronic hemodialysis patients\u2014results of a prospective study. J Med Life. 2016;9(4):449-454.","journal-title":"J Med Life"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.202404"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2008.08.012"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000101484"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139888901201208"},{"issue":"3","key":"e_1_3_2_39_2","first-page":"539","article-title":"Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status","volume":"54","author":"Checheri\u0163\u0103 IA","year":"2013","unstructured":"Checheri\u0163\u0103 IA, David C, Cioc\u00e2lteu A, Lasc\u0103r I, Budal\u0103 L. Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status. Rom J Morphol Embryol. 2013;54(3):539-543.","journal-title":"Rom J Morphol Embryol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087195"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12710"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg472"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000479641"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000080316.37254.7A"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1159\/000531267"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14483"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13920"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac128"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.433"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000537"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-020-00302-y"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1177\/20543581241256774"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6657188"},{"issue":"1","key":"e_1_3_2_54_2","article-title":"Correction of chronic metabolic acidosis for chronic kidney disease patients","volume":"2007","author":"Roderick P","year":"2007","unstructured":"Roderick P, Willis NS, Blakeley S, Jones C, Tomson C. Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev. 2007;2007(1):CD001890.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.10.011"}],"container-title":["Canadian Journal of Kidney Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20543581251356182","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20543581251356182","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20543581251356182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:21:59Z","timestamp":1777389719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20543581251356182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"alternative-id":["10.1177\/20543581251356182"],"URL":"https:\/\/doi.org\/10.1177\/20543581251356182","relation":{},"ISSN":["2054-3581","2054-3581"],"issn-type":[{"value":"2054-3581","type":"print"},{"value":"2054-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"article-number":"20543581251356182"}}